Liu M, Kong XY, Yao Y, Wang XA, Yang W, Wu H, Li S, Ding JW, Yang J
Moreover, if the exendin 2029 mass effective for pain relief (20 g) was intraperitoneally injected into wild-type mice without glucose treatment, changes in blood glucose levels were not detected
When tested as a once-daily injection in single and multiple doses varying up to 0.18 mg in healthy normal to overweight volunteers, gastrointestinal adverse events (nausea, diarrhoea, constipation, vomiting) were encountered, but the drug was described as well tolerated
Hunter DJ, Schofield D, Callander E
Its not unusual for patients to stop taking GLP-1 drugs in the real world beyond these clinical trials, notes Marilyn Tan, MD, a professor at Stanford University School of Medicine and chief of the endocrine clinic at Stanford Health Care in California
Differential analysis of intestinal microbiota and metabolites in mice with dextran sulfate sodium-induced colitis